Tokyo, Japan and Cambridge, UK, 14 February 2025 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) provides an ...

As part of Olive Tree Development's orientations to expand in the real estate market and with an ambitious plan during the ...

Astera Labs Inc (NASDAQ:ALAB) shares are trading lower Tuesday on the heels of the company's fourth-quarter financial results ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Aker Solutions' revenue rose 43% in the fourth quarter of 2024, and the company expects a solid order backlog in 2025 ...

Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...

Amgen outperformed expectations in the fourth quarter of 2024, but revealed an FDA hold on early-stage obesity asset AMG 513 ...

As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

Kinross Gold reported increased adjusted net earnings and a record free cash flow in 2024, as the company works toward proceeding with mining at the Redbird open pit at the ...

The nation’s largest recreational boat and yacht dealer now operates out of the Nielsen Media Research campus at 502 Brooker ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.